New drug cocktail aims to stop smoldering myeloma in its tracks
Disease control
Recruiting now
This study tests whether combining two drugs (teclistamab or talquetamab with daratumumab) can delay or prevent multiple myeloma in 50 people with high-risk smoldering myeloma. Participants receive the drug combination and are monitored for side effects and whether the cancer bec…
Phase: PHASE2 • Sponsor: Carl Ola Landgren, MD, PhD • Aim: Disease control
Last updated May 14, 2026 12:05 UTC